Cargando…

Risk Factors for Healthcare-Associated Extensively Drug-Resistant Acinetobacter baumannii Infections: A Case-Control Study

The emergence of extensively drug-resistant Acinetobacter baumannii (XDRAB) is a serious threat to hospitalized patients. From 2008 to 2010, surveillance detected 25 hospital-acquired infection (HAI) cases caused by XDRAB at a medical center in Taipei. The site of XDRAB infection was bloodstream (n ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Ming-Chin, Chiu, Sheng-Kang, Hsueh, Po-Ren, Wang, Ning-Chi, Wang, Chih-Chien, Fang, Chi-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897568/ https://www.ncbi.nlm.nih.gov/pubmed/24465819 http://dx.doi.org/10.1371/journal.pone.0085973

Ejemplares similares

Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Using the Chinese herb Scutellaria barbata against extensively drug-resistant Acinetobacter baumannii infections: in vitro and in vivo studies
por: Tsai, Chin-Chuan, et al.
Publicado: (2018)

Excess mortality and long-term disability from healthcare-associated carbapenem-resistant Acinetobacter baumannii infections: A nationwide population-based matched cohort study
por: Su, Chiu-Hsia, et al.
Publicado: (2023)

Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection
por: Wang, Jiun-Ling, et al.
Publicado: (2018)

Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014)

Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in Taiwan
por: Kuo, Shu-Chen, et al.
Publicado: (2013)

Sulbactam enhances the in vitro activity of sitafloxacin against extensively-drug resistant Acinetobacter baumannii
por: Xu, Nannan, et al.
Publicado: (2018)

Extensively drug-resistant Acinetobacter baumannii: role of conjugative plasmids in transferring resistance
por: Ababneh, Qutaiba, et al.
Publicado: (2023)

Synergistic Antibacterial Effect of Casein-AgNPs Combined with Tigecycline against Acinetobacter baumannii
por: Chen, Yu-Hsuan, et al.
Publicado: (2021)

Analysis on distribution features and drug resistance of clinically isolated Acinetobacter baumannii
por: Ren, Guangming, et al.
Publicado: (2016)

Functional Characterization of Acinetobacter baumannii Lacking the RNA Chaperone Hfq
por: Kuo, Han-Yueh, et al.
Publicado: (2017)

Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?
por: Wang, Yung-Chih, et al.
Publicado: (2020)

Draft Genome Sequence of an Extensively Drug-Resistant Acinetobacter baumannii Indigo-Pigmented Strain
por: Traglia, German, et al.
Publicado: (2014)

Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
por: Trebosc, Vincent, et al.
Publicado: (2019)

Antimicrobials Are a Photodynamic Inactivation Adjuvant for the Eradication of Extensively Drug-Resistant Acinetobacter baumannii
por: Wozniak, Agata, et al.
Publicado: (2019)

Treatment of severe ventriculitis caused by extensively drug-resistant Acinetobacter baumannii by intraventricular lavage and administration of colistin
por: Chen, FuMei, et al.
Publicado: (2019)

In vitro activity of biofilm inhibitors in combination with antibacterial drugs against extensively drug-resistant Acinetobacter baumannii
por: Peng, Qin, et al.
Publicado: (2020)

Draft Genome Sequence of Extensively Drug-Resistant Acinetobacter baumannii Strain CUAB1 from a Patient in Hong Kong, China
por: Yim, Aldrin Kay-Yuen, et al.
Publicado: (2015)

The Impact of Inadequate Terminal Disinfection on an Outbreak of Imipenem-Resistant Acinetobacter baumannii in an Intensive Care Unit
por: Liu, Wei-Lun, et al.
Publicado: (2014)

Colonization With Extensively Drug-Resistant Acinetobacter baumannii and Prognosis in Critically Ill Patients: An Observational Cohort Study
por: Zheng, Yue, et al.
Publicado: (2021)

Characterization of Carbapenemases in Extensively Drug Resistance Acinetobacter baumannii in a Burn Care Center in Iran
por: Azimi, Leila, et al.
Publicado: (2015)

Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
por: Mohammed, Mostafa A., et al.
Publicado: (2020)

Complete Genome Sequences of Four Extensively Drug-Resistant Acinetobacter baumannii Isolates from Thailand
por: Chopjitt, Peechanika, et al.
Publicado: (2020)

Whole-Genome-Sequence-Based Characterization of Extensively Drug-Resistant Acinetobacter baumannii Hospital Outbreak
por: Makke, Ghiwa, et al.
Publicado: (2020)

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
por: Dagher, Michael, et al.
Publicado: (2020)

Nosocomial transmission of extensively drug resistant Acinetobacter baumannii strains in a tertiary level hospital
por: López-Durán, Paúl Alexis, et al.
Publicado: (2020)

Investigations on Acinetophage, QAB 3.4, Targeting Extensively Drug-Resistant Acinetobacter baumannii Isolates
por: Hussain, Aamir, et al.
Publicado: (2021)

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates
por: Deolankar, Manas S., et al.
Publicado: (2022)

Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?
por: Cheng, Aristine, et al.
Publicado: (2017)

Control of Healthcare-Associated Carbapenem-Resistant Acinetobacter baumannii by Enhancement of Infection Control Measures
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan
por: Hsueh, Po-Ren, et al.
Publicado: (2002)

A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection
por: Deng, Zi-Wei, et al.
Publicado: (2019)

Global Transcriptomic Analysis of the Interactions between Phage φAbp1 and Extensively Drug-Resistant Acinetobacter baumannii
por: Yang, Zichen, et al.
Publicado: (2019)

Isolation and Characterization of φkm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii
por: Shen, Gwan-Han, et al.
Publicado: (2012)

In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
por: Lee, Hyukmin, et al.
Publicado: (2016)

Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1
por: Luna, Brian M., et al.
Publicado: (2017)

Acinetobacter baumannii infections in Amazon Region driven by extensively drug resistant international clones, 2016-2018
por: Caldart, Raquel Vosges, et al.
Publicado: (2019)

Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
por: Ye, Jung-Jr, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sjbkb3hucgk57df64u0v5gnom9